Literature DB >> 18638751

The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.

L Lefrancois1, D S Lyles.   

Abstract

Monoclonal antibodies reactive with the major surface glycoprotein (G-protein) of vesicular stomatitis virus serotypes Indiana and New Jersey (VSV-Ind, VSV-NJ) have been isolated and characterized. The reactivity of each monoclonal was determined by enzyme-linked immunosorbent assay (ELISA), competitive binding assay (CBA), and the ability to neutralize infectivity. It was found that the majority of the antibodies were of the IgG(2a) subclass. In the CBA, unlabeled monoclonal antibodies were used to compete for radiolabeled antibodies in binding to solid-phase immunoadsorbents. The VSV-NJ G-protein appears to contain four nonoverlapping epitopes by these analyses. However, the VSV-Ind G-protein is more complex since four epitopes were defined which exhibited varying degrees of overlap. In some cases, this overlap was defined by complete reciprocal competition between antibodies with different reactivity patterns. In other instances, partial or nonreciprocal competition between antibodies was observed. These results may indicate epitopes in close proximity or suggest allosteric modifications in the G-protein induced by antibody binding. A fifth epitope on the Ind G-protein was defined by a monoclonal antibody which could bind to the G-proteins of both VSV-Ind and VSV-NJ but could only neutralize infectivity of the VSV-Ind serotype.

Entities:  

Year:  1982        PMID: 18638751

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  65 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.

Authors:  E B Flanagan; L A Ball; G W Wertz
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Genetic inactivation of COPI coatomer separately inhibits vesicular stomatitis virus entry and gene expression.

Authors:  David K Cureton; Rebeca Burdeinick-Kerr; Sean P J Whelan
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons.

Authors:  Yo Sasaki; Jeffrey Milbrandt
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

5.  Biochemical analysis of constitutive secretion in a semiintact cell system.

Authors:  S G Miller; H P Moore
Journal:  Cell Biophys       Date:  1991 Oct-Dec

6.  Basic residues in the foamy virus Gag protein.

Authors:  Daniel Matthes; Tatiana Wiktorowicz; Juliane Zahn; Jochen Bodem; Nicole Stanke; Dirk Lindemann; Axel Rethwilm
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

7.  Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein.

Authors:  Chad E Mire; Derek Dube; Sue E Delos; Judith M White; Michael A Whitt
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

9.  Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Authors:  Jasmin Hettich; Scott D Ryan; Osmar Norberto de Souza; Luís Fernando Saraiva Macedo Timmers; Shelun Tsai; Nadia A Atai; Cintia C da Hora; Xuan Zhang; Rashmi Kothary; Erik Snapp; Maria Ericsson; Kathrin Grundmann; Xandra O Breakefield; Flávia C Nery
Journal:  Hum Mutat       Date:  2014-07-17       Impact factor: 4.878

10.  Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach.

Authors:  Claire Marie Filone; Erin N Hodges; Brian Honeyman; G Guy Bushkin; Karla Boyd; Andrew Platt; Feng Ni; Kyle Strom; Lisa Hensley; John K Snyder; John H Connor
Journal:  Chem Biol       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.